Zachariah Mareena S, Dwivedi Alok K, Yip Cindy S, Chang Shirley S, Gundroo Aijaz, Venuto Rocco C, Tomaszewski John, Patel Sunil K, Sharma Rajeev
From Department of Internal Medicine, Division of Nephrology, SUNY at the University at Buffalo, Buffalo, NY, USA.
Exp Clin Transplant. 2018 Aug;16(4):391-400. doi: 10.6002/ect.2016.0323. Epub 2017 Dec 5.
Prognostic implications of early protocol biopsies have been studied; however, the value of late protocol biopsy in predicting graft outcome has not been well defined. Here, we compared the effects of early and late protocol biopsy histologic findings in stable kidney allografts and aimed to understand the significance of "borderline" rejection on allograft function.
We studied 261 biopsies from 159 renal transplant recipients who were on a steroid-free, calcineurin inhibitor and mycophenolate mofetil regimen and who received transplants between 2004 and 2012 with mean follow-up of 5 years. Early (between 3 and 9 mo) and subsequent late (between 12 and 24 mo) protocol biopsies were performed. Biopsies were classified as normal, interstitial fibrosis and/or tubular atrophy, subclinical acute rejection with interstitial fibrosis and/or tubular atrophy, and borderline rejection with interstitial fibrosis and/or tubular atrophy. A linear mixed-effects model was used to determine the effects of early and late protocol biopsies on estimated glomerular filtration rate changes, with baseline time for estimated glomerular filtration rate fixed at 12 months.
The adjusted model showed that estimated glomerular filtration rate at 3 months, donor age, delayed graft function, and early protocol biopsies were associated with baseline estimated glomerular filtration rate at 12 months. Estimated glomerular filtration rate changes over time were associated with findings of interstitial fibrosis and/or tubular atrophy at early biopsy and subclinical acute rejection and borderline rejection at late biopsy. At last follow-up, final estimated glomerular filtration rate was significantly associated with interstitial fibrosis and/or tubular atrophy at early biopsy and with subclinical acute rejection at late biopsy.
Although early protocol biopsy predicted baseline estimated glomerular filtration rate, late biopsy was important for predicting changes in function over time. In addition, a diagnosis of "borderline" rejection on protocol biopsies predicted long-term graft function.
已对早期方案活检的预后意义进行了研究;然而,晚期方案活检在预测移植肾结局方面的价值尚未明确界定。在此,我们比较了早期和晚期方案活检组织学结果对稳定肾移植受者的影响,并旨在了解“临界”排斥反应对移植肾功能的意义。
我们研究了159例肾移植受者的261份活检样本,这些受者采用无类固醇、钙调神经磷酸酶抑制剂和霉酚酸酯治疗方案,于2004年至2012年接受移植,平均随访5年。进行了早期(3至9个月)及随后的晚期(12至24个月)方案活检。活检结果分为正常、间质纤维化和/或肾小管萎缩、伴有间质纤维化和/或肾小管萎缩的亚临床急性排斥反应以及伴有间质纤维化和/或肾小管萎缩的临界排斥反应。采用线性混合效应模型确定早期和晚期方案活检对估计肾小球滤过率变化的影响,估计肾小球滤过率的基线时间固定为12个月。
校正模型显示,3个月时的估计肾小球滤过率、供体年龄、移植肾功能延迟以及早期方案活检与12个月时的基线估计肾小球滤过率相关。估计肾小球滤过率随时间的变化与早期活检时的间质纤维化和/或肾小管萎缩以及晚期活检时的亚临床急性排斥反应和临界排斥反应相关。在最后一次随访时,最终估计肾小球滤过率与早期活检时的间质纤维化和/或肾小管萎缩以及晚期活检时的亚临床急性排斥反应显著相关。
尽管早期方案活检可预测基线估计肾小球滤过率,但晚期活检对于预测功能随时间的变化很重要。此外,方案活检诊断为“临界”排斥反应可预测移植肾的长期功能。